Skip to main content
SpringerLink
Log in

Letrozole an economic 2nd-line therapy for advanced breast cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Letrozole an economic 2nd-line therapy for advanced breast cancer. Pharmacoecon. Outcomes News 285, 9 (2000). https://doi.org/10.1007/BF03268923

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03268923

Keywords

Search

Navigation